Ipca Laboratories Ltd.

View in App
1371.20 +29.35 ▲2.2%

18 April 2024, 04:01:00 PM
Volume: 21,126

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ipca.com
Market Cap 34,787.92 Cr.
Enterprise Value(EV) 35,497.53 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 22.24 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 61.65 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 251.13 Trailing Twelve Months Ending 2023-12
Price to Book Value 5.46 Calculated using Price: 1,371.20
Dividend Yield 0.29 Period Ending 2023-03
No. of Shares Subscribed 25.37 Cr. 253,704,218 Shares
FaceValue 1
About Ipca Laboratories Ltd.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Ipca Laboratories is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India

Ipca Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ipca Laboratories Ltd. Performance

View details >>
1 Day
+2.19%
1 Week
+3.64%
1 Month
+17.76%
3 Month
+20.99%
6 Month
+42.31%
1 Year
+67.31%
2 Year
+31.54%
5 Year
+191.45%
10 Year
+249.10%

Ipca Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 12.43 4.31 8.25 9.31 15.22 17.92 27.63 17.92 8.7
Return on Capital Employed (%) 13.78 4.82 9.18 9.81 16.48 19.71 30.92 20.46 11.71
Return on Assets (%) 7.38 2.5 4.96 5.93 10.21 12.31 20.29 13.31 6.06

Ipca Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2,208 2,259 2,455 2,689 3,122 3,627 4,702 5,465 5,842 6,149
Non Curr. Liab. 700 663 548 419 313 290 190 614 902 1,127
Curr. Liab. 904 970 956 1,008 1,098 1,326 1,161 1,466 1,806 2,686
Minority Int. 16 14 15 77 73 1,412
Equity & Liab. 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,622 8,623 11,374
Non Curr. Assets 2,198 2,270 2,218 2,170 2,171 2,402 2,629 3,164 3,434 5,655
Curr. Assets 1,614 1,622 1,742 1,945 2,378 2,856 3,437 4,447 5,189 5,720
Misc. Exp. not W/O
Total Assets 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,622 8,623 11,374

Ipca Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 3,144 2,867 3,156 3,258 3,746 4,619 5,395 5,797 6,204 7,186
Other Income 59 41 55 58 75 87 129 122 152 142
Total Income 3,203 2,908 3,211 3,316 3,820 4,706 5,524 5,918 6,356 7,328
Total Expenditure -2,630 -2,593 -2,741 -2,816 -3,067 -3,729 -3,914 -4,539 -5,301 -6,045
PBIDT 573 314 470 500 753 977 1,610 1,379 1,055 1,284
Interest -32 -35 -27 -28 -22 -20 -12 -11 -48 -127
Depreciation -180 -163 -173 -178 -182 -211 -209 -232 -262 -329
Taxation -102 -20 -68 -51 -104 -135 -240 -225 -253 -288
Exceptional Items 68
PAT 259 96 195 239 442 604 1,149 911 492 607
Minority Interest 3 3 -1 -6 -8 -35
Share Associate -5 -3 -8 -21 -13 -8
Other Related Items
Consolidated Net Profit 254 93 195 239 446 606 1,140 884 471 564
Adjusted EPS 10 4 8 9 18 24 45 35 19 22

Ipca Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 522 468 709 282 341 501 570 1,090 856 806
Cash Fr. Inv. -369 -689 -218 -149 -135 -165 -510 -521 -855 -725
Cash Fr. Finan. -136 251 -462 -159 -130 -183 -137 -306 427 507
Net Change 17 29 29 -26 75 153 -76 264 428 588
Cash & Cash Eqvt 74 104 169 143 218 371 295 559 991 1,579

Ipca Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 46.29 46.29 46.29 46.29 46.29 46.29 46.29 46.29 46.30
Public 53.71 53.71 53.71 53.71 53.71 53.70 53.71 53.71 53.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Ipca Laboratories Ltd. Announcements

View details >>
Wed, 17 Apr 2024
Allotment Of Equity Shares Of Lyka Labs Ltd. On Conversion Of Warrants
Allotment of equity shares of Lyka Labs Ltd. on conversion of warrants
Wed, 10 Apr 2024
Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Compliance Certificate under Regulation 7(3) of the SEBI (LODR) Regulations 2015.
Tue, 09 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended 31 March 2024..

Ipca Laboratories Ltd. Technical Scans

View details >>
Tue, 16 Apr 2024
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Ipca Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 368,765.79 1,523.80 -0.9%
Cipla Ltd. 111,101.58 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. 100,958.41 5,959.10 -1.5%
Divi's Laboratories Ltd. 99,939.63 3,717.35 -1.3%
Zydus Lifesciences Ltd. 95,104.21 934.50 -1.1%
Mankind Pharma Ltd. 91,420.29 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. 91,073.20 6,107.00 -3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.41 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 29.96 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.31 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 72.26 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.98 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-12 52.93 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.38 6,107.00 -3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.91 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 4.29 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.76 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.67 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.05 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-12 10.29 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.48 6,107.00 -3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,107.00 -3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,107.00 -3.6%

Ipca Laboratories Ltd. FAQ's

What is Ipca Laboratories share price?
Can I buy Ipca Laboratories shares now?
What is the Dividend Yield of Ipca Laboratories?
What is the Market Cap of Ipca Laboratories?
What are the key metrics to analyse Ipca Laboratories?
What is the 52 Week High and Low of Ipca Laboratories?
What is the trend of Ipca Laboratories share price?